Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.50 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30621980 | 0.88 | TACR1 (0.80) | TACR1ALDH1A1POLBALOX15CTSK | |
| SCHEMBL28750936 | 0.86 | TACR1 (0.61) | TACR1ALDH1A1CA12CA1CA2 | |
| SCHEMBL27895749 | 0.86 | TACR1 (0.61) | TACR1ALDH1A1CA12CA1CA2 | |
| SCHEMBL24451342 | 0.86 | TACR1 (0.61) | TACR1ALDH1A1CA12CA1CA2 | |
| SCHEMBL30621976 | 0.86 | TACR1 (0.61) | TACR1ALDH1A1CA12CA1CA2 | |
| SCHEMBL2677964 | 0.86 | CTSK (0.57) | TACR1ALDH1A1ALOX15CTSKCTSS | |
| SCHEMBL7032185 | 0.86 | CTSK (0.57) | TACR1ALDH1A1ALOX15CTSKCTSS | |
| SCHEMBL17446717 | 0.86 | CTSK (0.57) | TACR1ALDH1A1ALOX15CTSKCTSS | |
| SCHEMBL18775048 | 0.85 | CTSK (0.60) | TACR1ALDH1A1CTSKCTSS | |
| Hydrochloric Acid SCHEMBL6940517 | 0.85 | TACR1 (0.60) | TACR1ALDH1A1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116947858-A | Compounds selectively inhibiting four amino acid modifications of ADP, preparation and application thereof | 首都医科大学 | 2023-10-27 | — | — | CN | claimed |
| CN-116947858-A | Compounds selectively inhibiting four amino acid modifications of ADP, preparation and application thereof | 首都医科大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-111995626-B | 6- (acetyl-AA-mercapto) purine, its synthesis, activity and use | 首都医科大学 | 2023-06-27 | — | — | CN | disclosed |
| CN-112110925-B | 6- (acetyl-AA-mercapto) purine, its synthesis, activity and use in combination with cisplatin | 首都医科大学 | 2023-06-27 | — | — | CN | disclosed |
| US-20080090785-A1 | Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents | PROTEOLIX, INC. (US) | 2008-04-17 | — | — | US | disclosed |
| WO-1994005676-A1 | NOVEL PHOSPHO AND PHOSPHONO-(N-ACYL)-SERINES AND THEIR PRODUCTION | Max-Delbrück-Centrum für Molekulare Medizin (DE) | 1994-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090785-A1 | Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents | ANPEP, DNPEP, CPN1 | TACR1 1246/4885ALDH1A1 3376/4885CA12 3763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.